The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance
- Dharminder Chauhan
- , Guilan Li
- , Klaus Podar
- , Teru Hideshima
- , Reshma Shringarpure
- , Laurence Catley
- , Constantine Mitsiades
- , Nikhil Munshi
- , Yu Tzu Tai
- , Nanjoo Suh
- , Gordon W Gribble
- , Tadashi Honda
- , Robert Schlossman
- , Paul Richardson
- , Michael B Sporn
- , Kenneth C Anderson
Research output: Journal article (peer-reviewed) › Journal article
106
Link opens in a new tab
Citations
(Scopus)